You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 2, January 26, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Randomized Controlled Trial
 •Psychiatry
 •Adverse Effects
 •Alert me on articles by topic

Conceptual Foundations of the UCSD Statin Study

A Randomized Controlled Trial Assessing the Impact of Statins on Cognition, Behavior, and Biochemistry

Beatrice Alexandra Golomb, MD, PhD; Michael H. Criqui, MD, MPH; Halbert White, PhD; Joel E. Dimsdale, MD

Arch Intern Med. 2004;164:153-162.

Background  Statin cholesterol-lowering drugs are among the most prescribed drugs in the United States. Their cardiac benefits are substantial and well supported. However, there has been persistent controversy regarding possible favorable or adverse effects of statins or of cholesterol reduction on cognition, mood, and behavior (including aggressive or violent behavior).

Methods  The literature pertaining to the relationship of cholesterol or statins to several noncardiac domains was reviewed, including the link between statins (or cholesterol) and cognition, aggression, and serotonin.

Results  There are reasons to think both favorable and adverse effects of statins and low cholesterol on cognition may pertain; the balance of these factors requires further elucidation. A substantial body of literature links low cholesterol level to aggressive behavior; statin randomized trials have not supported a connection, but they have not been designed to address this issue. A limited number of reports suggest a connection between reduced cholesterol level and reduced serotonin level, but more information is needed with serotonin measures that are practical for clinical use. Whether lipophilic and hydrophilic statins differ in their impact should be assessed.

Conclusion  There is a strong need for randomized controlled trial data to more clearly establish the impact of hydrophilic and lipophilic statins on cognition, aggression, and serotonin, as well as on other measures relevant to risks and quality-of-life impact in noncardiac domains.


From the Departments of Medicine (Drs Golomb and Criqui), Economics (Dr White), Psychiatry (Dr Dimsdale), Family and Preventive Medicine (Drs Golomb and Criqui), and Psychology (Dr Golomb), University of California, San Diego. The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reduction in Blood Pressure With Statins: Results From the UCSD Statin Study, a Randomized Trial
Golomb et al.
Arch Intern Med 2008;168:721-727.
ABSTRACT | FULL TEXT  

Neurobiology of Aggression and Violence
Siever
Am. J. Psychiatry 2008;165:429-442.
ABSTRACT | FULL TEXT  

The Use of Statins in Pediatrics: Knowledge Base, Limitations, and Future Directions
Belay et al.
Pediatrics 2007;119:370-380.
ABSTRACT | FULL TEXT  

Outcomes in 45 Patients With Statin-Associated Myopathy
Hansen et al.
Arch Intern Med 2005;165:2671-2676.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.